36 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
with the privacy policy of the Company.
Minimum Requirements. Nothing in the Agreement is intended to contract out of any minimal substantive or procedural
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security
8-K
EX-10.1
wixlcztv
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
5mq2t0ylbefehq4w8
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
424B5
evozz3lfun6n 14
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
a4nq2
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
hx9bnxwo3lqhhgrz8 0j
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
eo37ajyogpi4q2
7 Apr 22
Prospectus supplement
4:46pm
S-3
mwngzo0
4 Feb 22
Shelf registration
4:36pm
8-K
EX-2.1
dj1yek
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
acypt78t5 ykg
24 Sep 21
Annual report
7:31am
10-K
vped0q0a3i5m
24 Sep 21
Annual report
7:31am
424B3
7spxu07f8oxq1upr33ud
22 Jul 21
Prospectus supplement
10:27am